XML 189 R68.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant restructuring transaction, mergers and acquisitions and equity investments- Alibaba Health (Details)
shares in Millions, $ in Millions, $ in Millions
1 Months Ended 12 Months Ended
May 31, 2018
HKD ($)
shares
Jan. 31, 2018
HKD ($)
shares
Jan. 31, 2018
CNY (¥)
shares
Jun. 30, 2017
CNY (¥)
shares
Jul. 31, 2015
CNY (¥)
Apr. 30, 2014
HKD ($)
Apr. 30, 2014
CNY (¥)
Mar. 31, 2018
USD ($)
Mar. 31, 2018
CNY (¥)
Mar. 31, 2017
CNY (¥)
Mar. 31, 2016
CNY (¥)
Mar. 31, 2018
CNY (¥)
Jul. 31, 2015
HKD ($)
Jul. 31, 2015
CNY (¥)
Acquisition                            
Noncontrolling interests               $ 11,258   ¥ 42,330,000,000   ¥ 70,616,000,000    
Payments to acquire interest in subsidiaries               8,568 ¥ 53,742,000,000 39,429,000,000 ¥ 37,625,000,000      
The allocation of the equity value at the date of the deemed acquisition                            
Goodwill               $ 25,850   ¥ 125,420,000,000 81,645,000,000 ¥ 162,149,000,000    
Developed technology and patents | Maximum                            
The equity value is comprised of:                            
Estimated amortization periods               5 years 5 years          
Trade names, trademarks and domain names | Maximum                            
The equity value is comprised of:                            
Estimated amortization periods               20 years 20 years          
User base and customer relationships | Maximum                            
The equity value is comprised of:                            
Estimated amortization periods               16 years 16 years          
Alibaba Health                            
Acquisition                            
Issuance of ordinary shares (in shares) | shares       1,200                    
Equity interest held (as a percentage)                         54.00% 54.00%
Equity interest held in subsidiary (as a percentage)       46.00%       48.00%       48.00% 38.00% 38.00%
Equity value                         $ 64,319 ¥ 50,723,000,000
Gain recognized in relation to the revaluation of previously held equity interest relating to obtaining control                     ¥ 18,603,000,000      
Noncontrolling interests     ¥ 468,000,000 ¥ 3,962,000,000                    
Payments to acquire interest in subsidiaries   $ 1,770 ¥ 1,469,000,000                      
The allocation of the equity value at the date of the deemed acquisition                            
Net assets acquired                           1,290,000,000
Goodwill                           49,320,000,000
Deferred tax assets                           19,000,000
Deferred tax liabilities                           (19,000,000)
Total                         $ 64,319 50,723,000,000
The equity value is comprised of:                            
- fair value of previously held equity interests         ¥ 19,264,000,000                  
- fair value of noncontrolling interests         31,459,000,000                  
Total         ¥ 50,723,000,000                  
Weighted average amortization period         2 years 7 months 6 days                  
Alibaba Health | Future                            
Acquisition                            
Equity interest held in subsidiary (as a percentage) 56.00%                          
Alibaba Health | Maximum                            
The equity value is comprised of:                            
Estimated amortization periods         3 years                  
Alibaba Health | Developed technology and patents                            
The allocation of the equity value at the date of the deemed acquisition                            
Amortizable intangible assets                           70,000,000
Alibaba Health | Trade names, trademarks and domain names                            
The allocation of the equity value at the date of the deemed acquisition                            
Amortizable intangible assets                           35,000,000
Alibaba Health | User base and customer relationships                            
The allocation of the equity value at the date of the deemed acquisition                            
Amortizable intangible assets                           ¥ 8,000,000
Alibaba Health | Ordinary Shares                            
Acquisition                            
Ordinary shares purchased | shares   442 442                      
Special purpose entity | Ordinary Shares                            
Acquisition                            
Equity interest (as a percent)           70.00% 70.00%              
Purchase consideration, equity method           $ 932 ¥ 741,000,000              
Alibaba Health | Yunfeng                            
Acquisition                            
Consideration paid to related party for giving up its voting rights with respect to its indirect interest in investee         ¥ 0                  
Alibaba Health | Ordinary Shares                            
Acquisition                            
Equity interest (as a percent)           38.00% 38.00%              
Company and Yunfeng | Alibaba Health | Ordinary Shares                            
Acquisition                            
Percentage of equity interest acquired           54.00% 54.00%              
Alibaba Health | Tmall China | Future                            
Acquisition                            
Aggregate consideration | $ $ 10,600                          
Shares issued in transaction | shares 1,800